Abstract
The invention of the Polymerase Chain Reaction (PCR) has revolutionized molecular biology enabling gene isolation and characterization in hours rather than days. Scientists working in transplant diagnostics have proven to be pioneers in adapting this molecular technique to the clinical needs of histocompatibility testing. This chapter describes a number of novel genoty** technologies which have been used to address the challenges posed by genetic diversity seen in the extensive polymorphism in HLA genes. These novel approaches include single-stranded and duplex conformational analyses, real-time PCR, microarray hybridization, RNA-based sequencing, and the present day Next Generation Sequencing. The chapter concludes with a brief look at a possible next, Next Generation Sequencing system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
McCluskey J, Peh CA (1999) The human leukocyte antigens and clinical medicine: an overview. Rev Immunogenet 1:3–20
Tiercy J-M (2002) Molecular basis of HLA polymorphism: implications in clinical transplantation. Transpl Immunol 9:173–180
Tait BD (2011) The ever expanding list of HLA alleles: changing HLA nomenclature its relevance to clinical transplantation. Transplant Rev 25:1–8
Taylor CJ, Bolton EM, Bradley AJ (2011) Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans Roy Soc B 366:2312–2322
Thorsby E (2009) A short history of HLA. Tissue Antigens 74:101–116
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Middleton D (1999) History of DNA ty** for the human MHC. Rev Immunogenet 1:135–156
Bunce M, O’Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI (1995) Phototy**: comprehensive DNA ty** for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355–367
Cao K, Chopek M, Fernandez-Vina M (1999) High and intermediate resolution DNA ty** systems for class I HLA-A, -B, -C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev Immunogenet 1:177–208
Dunn PPJ, Day S, Williams S, Bendukidze N (2003) HLA sequencing as a tissue ty** tool. In: Goulding N, Seward C (eds) Pediatric hematology. Humana Press, Totowa, NJ
Guo Z, Hood L, Petersdorf EW (1999) Oligonucleotide arrays for high resolution HLA ty**. Rev Immunogenet 1:220–230
Holcomb CL, Höglund B, Anderson MW, Böhme I, Egholm M, Ferriola D et al (2011) A multi-site study using high resolution HLA genoty** by next generation sequencing. Tissue Antigens 77:206–217
Dunn PPJ (2011) HLA ty**: techniques and technology, a critical appraisal. Int J Immunogenet 38:463–473
Wang H, Tokunaga K, Ishikawa Y, Tanaka H, Kashiwase K, Shibata Y, Juji T (1997) A high-resolution genoty** method for HLA-C alleles and possible shared HLA-C-B haplotypes between Japanese and Caucasians. Tissue Antigens 50:620–626
Knapp LA, Lehmann E, Hennes M, Eberle ME, Watkins DI (1997) High-resolution HLA-DRB ty** using denaturing gradient gel electrophoresis and direct sequencing. Tissue Antigens 50:170–177
Arguello JR, Pay AL, McDermott A, Ross J, Dunn P, Avakian H, Little A-M, Goldman J, Madrigal JA (1997) Complementary strand analysis, a new approach for allelic separation in complex polyallelic genetic systems. Nucleic Acids Res 25:2236–2238
Arguello JR, Little A-M, Pay AL, Gallardo D, Rojas I, Marsh SG, Goldman JM, Madrigal JA (1998) Mutation detection and ty** of polymorphic loci through double-strand conformation analysis. Nat Genet 18:192–194
Arguello JR, Madrigal JR (1999) HLA ty** by reference strand mediated conformation analysis (RSCA). Rev Immunogenet 1:209–219
Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A (2003) Physical separation of HLA-A alleles by denaturing high performance liquid chromatography. Tissue Antigens 61:443–450
Kuzio S, Hanguehard A, Morelle M, Ronsin C (2004) Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe. J Immunol Methods 287:179–186
Fan W, Huang L, Zhou Z, Zeng X, Li G, Deo P, Hi L, Li Y (2012) Rapid and reliable genoty** of HLA-B*27 in the Chinese Han population using a duplex real-time TaqMan PCR assay. Clin Biochem 45:106–111
Goris A, Walton A, Ban M, Dubois B, Compston A, Sawcer S (2008) A Taqman assay for high-throughput genoty** of the multiple sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens 72:401–403
Profaizer T, Eckels D, Delgado JC (2011) Coeliac disease and HLA ty** using real time PCR with melting curve analysis. Tissue Antigens 78:31–37
Kim SY, Chang HE, Song SH, Park KU, Song J (2011) Rapid genoty** of HLA-B27 among Korean population by real time PCR melting curve analysis. Clin Chim Acta 412:1912–1917
Hammond E, Mamotte C, Nolan D, Mallal S (2007) HLA-B*5701 ty**, evaluation of an allele-specific polymerase chain reaction melting assay. Tissue Antigens 70:58–61
Zhou L, Vandersteen J, Wang L, Fuller T, Taylor M, Palais B, Wittwer CT (2004) High resolution DNA melting curve analysis to establish HLA genotypic identity. Tissue Antigens 64:156–164
Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH, Setterholm M, Maiers M (2009) The HLA dictionary 2008, a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73:95–170
Dunbar SA (2006) Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 363:71–82
Cano P, Klitz W, Mack SJ, Marsh SGE, Noreen H, Reed EF, Senitzer D, Setterholm M, Smith A, Fernandez-Vina M (2007) Common and well-documented HLA alleles, report of the Ad-Hoc committee of the american society for histocompatibility and immunogenetics. Hum Immunol 68:392–417
Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D et al (2013) Common and well-documented HLA alleles, 2012 update to the CWD catalogue. Tissue Antigens 81:194–203
Guo Z, Gatterman MS, Hood L (2002) Oligonucleotide arrays for high-throughput SNPs detection in the MHC Class I Genes, HLA-B as a model system. Genome Res 12:447–457
Bang-Ce Y, ** of DRB1/3/4/5 loci by oligonucleotide microarray. J Mol Diagn 7:592–599
Palmisano GL, Delfino L, Fiore M, Longo A, Ferrara GB (2005) Single nucleotide polymorphisms detection based on DNA microarray technology, HLA as a model. Autoimmun Rev 4:510–514
Zhang F, Hu SW, Huang J, Wang H, Wen Z, Yongyao G, Wang S (2006) Development and clinical evaluation of oligonucleotide microarray for HLA-A, B genoty**. Pharmacogenomics 7:973–985
Lee KR, Park E, Moon SH, Kim JM, Kwon OJ, Kim MH, Sohn YH, Ko SY, Oh HB (2008) Development and clinical evaluation of a microarray for HLA-A and -DRB1 genoty**. Tissue Antigens 72:568–577
Lemeshko SV, Powdrill T, Belosludtsev YY, Hogan M (2001) Oligonucleotides form a duplex with non-helical properties on a positively-charged surface. Nucleic Acids Res 14:3051–3058
Feng C, Putonti C, Zhang M, Eggers R, Mitra R, Hogan M, Jayaraman K, Fofanov Y (2009) Ultraspecific probes for high throughput HLA ty**. BMC Genomics 10:85
Santamaria P, Boyce-Jacino MT, Lindstrom AL, Barbosa JJ, Faras AJ, Rich SS (1992) HLA class II ty**, direct sequencing of DRB, DQB and DQA genes. Hum Immunol 33:69–81
Santamaria P, Lindstrom AL, Boyce-Jacino MT, Myster SH, Barbosa JJ, Faras AJ, Rich SS (1993) HLA class I sequence-based ty**. Hum Immunol 37:39–50
Theseira M, Dunn PPJ (2011) Sequencing based HLA ty** using RNA. Genet Eng News 31:66–69
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463–5467
Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, Erlich HA (2009) High resolution, high-throughput HLA genoty** by next-generation sequencing. Tissue Antigens 74:393–403
Gabriel C, Danzer M, Hackl C, Kopal G, Hufnagl P, Hofer K, Polin H, Stabentheiner S, Proll J (2009) Rapid high throughput human leukocyte antigen ty** by massively parallel pyrosequencing for high resolution allele identification. Hum Immunol 70:960–964
De Santis D, Dinauer D, Duke J, Erlich HA, Holcomb CL, Lind C, Mackiewicz K, Monos D, Moudgil A, Norman P, Parham P, Sasson A, Allcock RJN (2012) 16th IHIW, Review of HLA ty** by NGS. Int J Immunogenet 40:72–76
Gabriel C, Furst D, Fae I, Wenda S, Zollikofer C, Mytilineos J, Fischer G (2014) HLA ty** by next-generation-sequencing – getting closer to reality. Tissue Antigens 83:65–75
Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG et al (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53–59
Wang C, Krishnakumar S, Wilhelmy J, Babrzadeh F, Stepanyan L, Su LF et al (2012) High-throughput, high-fidelity HLA genoty** with deep sequencing. Proc Natl Acad Sci U S A 109:8676–8681
Hosomichi K, **am TA, Mitsunaga S, Nakaoka H, Inoue I (2013) Phase defined complete sequencing of the HLA genes by next generation sequencing. BMC Genomics 14:355
Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M et al (2011) An integrated semiconductor device enabling non-optical genome sequencing. Nature 475:348–352
Shiina T, Suzuki S, Ozaki Y, Taira H et al (2012) Super high resolution for single molecule-sequence-based ty** of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens 80:305–316
Mayor N, Robinson J, McWhinnie A, Ranade S, Eng K, Bultitude WP, Midwinter W, Bowman B, Marks P, Braund H, Madrigal JA, Latham K, Marsh SGE (2014) Genomic DNA sequences of HLA class I alleles generated using multiplexed barcodes and SMRT DNA sequencing technology. Tissue Antigens 84:P155
Cahill N, Ameur A, Knutsson C, Orebrand U, Gyllensten U, Bengtsson M (2014) HLA ty** by SMRT sequencing: advantages of full length HLA genoty** in clinical routine. Tissue Antigens 84:P196
Howorka S, Cheley S, Bayley H (2001) Sequence-specific detection of individual DNA strands using engineered nanopores. Nat Biotech 19:636–639
Stoddart D, Heron AJ, Mikhailova E, Maglia G, Bayley H (2009) Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore. Proc Natl Acad Sci U S A 106:7702–7707
Kasianowicz JJ, Brandin E, Branton D, Deamer DW (1996) Characterization of individual polynucleotide molecules using a membrane channel. Proc Natl Acad Sci U S A 93:13770–13773
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Dunn, P.P.J. (2015). Novel Approaches and Technologies in Molecular HLA Ty**. In: Bugert, P. (eds) Molecular Ty** of Blood Cell Antigens. Methods in Molecular Biology, vol 1310. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2690-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2690-9_18
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2689-3
Online ISBN: 978-1-4939-2690-9
eBook Packages: Springer Protocols